Author details

Full Name

Dimitri Livitz

Affiliation

ORCID

Career Start Year

2014

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36624313	Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.	Nat Med	2023
37006772	Accelerating the Design of Self-Guided Microrobots in Time-Varying Magnetic Fields.		2023
35243413	Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.	Cell Rep Med	2022
35674495	Insights into Chemically Fueled Supramolecular Polymers.	Chemical Reviews	2022
34496240	Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer.	Cell Rep	2021
33684943	Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia.	Blood	2021
34112698	Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History.	Cancer Discov	2021
33331388	Programmable topotaxis of magnetic rollers in time-varying fields.	Soft Matter	2021
34729575	Automating Bayesian inference and design to quantify acoustic particle levitation.	Soft Matter	2021
33028839	Framework for quality assessment of whole genome cancer sequences.	Nat Commun	2020
31171663	RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues.	Science	2019
31745334	Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.	Nat Med	2019
31142838	Growth dynamics in naturally progressing chronic lymphocytic leukaemia.	Nature	2019
31543463	Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.	Cancer Cell	2019
31501609	Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.	Nat Med	2019
29713087	Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
30256787	Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma.	PLoS Genet	2018
30107175	Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in HÃ¼rthle Cell Carcinoma.	Cancer Cell	2018
29955181	Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29955182	Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.	Nat Med	2018
29717118	Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.	Nat Commun	2018
29109393	Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.	Nat Commun	2017
28825726	A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.	Nat Genet	2017
29872714	Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens.	NPJ Precis Oncol	2017
29259203	The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.	Nat Commun	2017
29070816	Resistance to checkpoint blockade therapy through inactivation of antigen presentation.	Nat Commun	2017
25223613	Two-dimensional gas chromatography/mass spectrometry, physical property modeling and automated production of component maps to assess the weathering of pollutants.	Journal of Chromatography A	2014